Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Pancreatic Neoplasms 66Carcinoma, Non-Small-Cell Lung 39Breast Neoplasms 32Triple Negative Breast Neoplasms 25Neoplasm Metastasis 18Neoplasms 15Lung Neoplasms 15Colorectal Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 6Ovarian Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Head and Neck Neoplasms 5Gallbladder Neoplasms 5Fallopian Tube Neoplasms 5Adenocarcinoma 5Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Cholangiocarcinoma 4Carcinoma, Pancreatic Ductal 4Carcinoma 4Neoplasms by Site 3Gastrointestinal Neoplasms 3Endometrial Neoplasms 3Brain Neoplasms 3Biliary Tract Neoplasms 3Vaccinia 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Small Cell Lung Carcinoma 2

Interventions

Nivolumab 11pembrolizumab 10Ipilimumab 9Cyclophosphamide 6tebentafusp 5Interleukin-2 4Blood Specimen Collection 4fludarabine phosphate 3fludarabine 3Specimen Handling 3Radiosurgery 3Melphalan 3Magnetic Resonance Spectroscopy 3relatlimab 2lenvatinib 2cemiplimab 2binimetinib 2aflibercept 2Surveys and Questionnaires 2Dacarbazine 2Crizotinib 2Carmustine 2Biopsy 2ulixertinib 1trametinib 1sargramostim 1ruxolitinib 1omipalisib 1olaparib 1lifileucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × 130-nm albumin-bound paclitaxel × 1 year × Clear all
NCT05075993 2025-12-26

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
352 enrolled
DermatologicGastrointestinalGynecologicSarcoma

Uveal Melanoma, Carcinoma, Hepatocellular, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡